These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 10623775)

  • 1. Modern approaches to treating acromegaly.
    Turner HE; Wass JA
    QJM; 2000 Jan; 93(1):1-6. PubMed ID: 10623775
    [No Abstract]   [Full Text] [Related]  

  • 2. Modern treatment of acromegaly.
    Merza Z
    Postgrad Med J; 2003 Apr; 79(930):189-93; quiz 192-4. PubMed ID: 12743333
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Contemporary options and perspectives in the treatment of acromegaly].
    Marek J
    Cas Lek Cesk; 2014; 153(3):131-6. PubMed ID: 24968290
    [TBL] [Abstract][Full Text] [Related]  

  • 4. GH receptor antagonist: mechanism of action and clinical utility.
    Surya SK; Barkan AL
    Rev Endocr Metab Disord; 2005 Jan; 6(1):5-13. PubMed ID: 15711909
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Advances in the treatment of acromegaly].
    Krysiak R; Okopień B; Marek B
    Pol Merkur Lekarski; 2008 Jan; 24(139):59-65. PubMed ID: 18634256
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Medical progress: Acromegaly.
    Melmed S
    N Engl J Med; 2006 Dec; 355(24):2558-73. PubMed ID: 17167139
    [No Abstract]   [Full Text] [Related]  

  • 7. Multidisciplinary management of acromegaly: A consensus.
    Giustina A; Barkhoudarian G; Beckers A; Ben-Shlomo A; Biermasz N; Biller B; Boguszewski C; Bolanowski M; Bollerslev J; Bonert V; Bronstein MD; Buchfelder M; Casanueva F; Chanson P; Clemmons D; Fleseriu M; Formenti AM; Freda P; Gadelha M; Geer E; Gurnell M; Heaney AP; Ho KKY; Ioachimescu AG; Lamberts S; Laws E; Losa M; Maffei P; Mamelak A; Mercado M; Molitch M; Mortini P; Pereira AM; Petersenn S; Post K; Puig-Domingo M; Salvatori R; Samson SL; Shimon I; Strasburger C; Swearingen B; Trainer P; Vance ML; Wass J; Wierman ME; Yuen KCJ; Zatelli MC; Melmed S
    Rev Endocr Metab Disord; 2020 Dec; 21(4):667-678. PubMed ID: 32914330
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Therapeutic management of acromegaly].
    Metzner C; Hadziselimovic S; Grafe I; Nawroth P; Kasperk C
    Med Klin (Munich); 2006 Jan; 101(1):15-23. PubMed ID: 16418810
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Newer options in the management of acromegaly.
    Burt MG; Ho KK
    Intern Med J; 2006 Jul; 36(7):437-44. PubMed ID: 16780450
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Could different treatment approaches in acromegaly influence life expectancy? A comparative study between Bulgaria and Campania (Italy).
    Colao A; Vandeva S; Pivonello R; Grasso LF; Nachev E; Auriemma RS; Kalinov K; Zacharieva S
    Eur J Endocrinol; 2014 Aug; 171(2):263-73. PubMed ID: 24878680
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Treatment of pituitary gland hyperfunction: from acromegaly to prolactinoma].
    Schäffler A
    Internist (Berl); 2006 Dec; 47(12):1215-6, 1218-20, 1222. PubMed ID: 17033781
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drug insight: Primary medical therapy of acromegaly.
    Katznelson L
    Nat Clin Pract Endocrinol Metab; 2006 Feb; 2(2):109-17; quiz following 117. PubMed ID: 16932265
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Current thinking on the management of the acromegalic patient.
    Katznelson L
    Curr Opin Endocrinol Diabetes Obes; 2007 Aug; 14(4):311-6. PubMed ID: 17940458
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cost-effectiveness analysis of preoperative treatment of acromegaly with somatostatin analogue on surgical outcome.
    Margusino-Framiñán L; Pertega-Diaz S; Pena-Bello L; Sangiao-Alvarellos S; Outeiriño-Blanco E; Pita-Gutierrez F; Pita-Fernandez S; Cordido F
    Eur J Intern Med; 2015 Nov; 26(9):736-41. PubMed ID: 26300269
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Growth hormone and its disorders.
    Ayuk J; Sheppard MC
    Postgrad Med J; 2006 Jan; 82(963):24-30. PubMed ID: 16397076
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Treatment of acromegaly].
    Dénes J; Korbonits M; Hubina E; Góth M
    Orv Hetil; 2010 Aug; 151(34):1384-93. PubMed ID: 20705553
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The treatment algorithm of acromegaly.
    Colao A; Pivonello R; Cappabianca P; Vitale G; Lombardi G
    J Endocrinol Invest; 2003; 26(8 Suppl):39-45. PubMed ID: 15233211
    [No Abstract]   [Full Text] [Related]  

  • 18. MANAGEMENT OF ENDOCRINE DISEASE: Personalized medicine in the treatment of acromegaly.
    Kasuki L; Wildemberg LE; Gadelha MR
    Eur J Endocrinol; 2018 Mar; 178(3):R89-R100. PubMed ID: 29339530
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Growth hormone receptor antagonists.
    van der Lely AJ; Kopchick JJ
    Neuroendocrinology; 2006; 83(3-4):264-8. PubMed ID: 17047392
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Guidelines for the diagnosis and treatment of acromegaly: a Canadian perspective.
    Patel YC; Ezzat S; Chik CL; Rorstad OP; Serri O; Ur E; Wilkins GE
    Clin Invest Med; 2000 Jun; 23(3):172-87. PubMed ID: 10911548
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.